4Loreen A, Herwaldt MD.Control of methicillin - resistant Staphylococcus aureus in the hospital setting (J) .Am J Medicine, 1999,106:11s - 18s.
5Adair CG, Gorman SP, Feron BM, et al. Implications of endor racheal tube bioflim for ventilator associcated pneumonia(J). Intensive Care Medicine, 1999,25:1072.
6Edelstein PH. Pneumococcal resistance to macrolides, lincosamides,ketolides,and streptogramin B agents: molecular mechanisms and resistance phenotypes[J]. Clin Infect Dis,2004,38(Suppl 4):S322-S327.
7Doktor SZ,Shortridge VD,Beyer JM, et al. Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations[J]. Diagn Microbiol Infect Dis,2004,49(1):47-52.
8Farrell DJ, Douthwaite S, Morrissey I, et al. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study [J]. Antimicrob Agents Chemother,2003,47(6):1777-1783.
